The Dean of CollegeStock.com Upper-Class Stock Picks of the Day for August 25, 2009 are Park Place Energy Corporation (OTCBB: PKPL), Biopack Environmental Solutions Inc. (OTCBBL BPAC), The Tootie Pie Company, Inc. (OTCBB: TOOT) and Viral Genetics (Pink Sheets: VRAL).
Park Place Energy Corporation (OTCBB: PKPL) announced today that the company has arrived at an agreement with a private Canada-based oil and gas exploration company to create a joint venture partnership on Park Place’s two Alberta Nordegg land sections.
Biopack Environmental Solutions Inc. (OTCBB: BPAC), a leading designer, manufacturer of biodegradable and compostable packing products, announced second quarter and year-to-date revenues of $403,101 and $663,498 respectively.
The Tootie Pie Company, Inc. (OTCBB: TOOT), a premium baker and seller of high-quality, homemade pies, announced today that the company’s products are now being carried by an eighth SYSCO location in Longivew, Texas.
Viral Genetics (Pink Sheets: VRAL)
Viral Genetics is a biotechnology company that discovers and develops immune-based therapies using its thymus nuclear protein compound for the treatment of HIV/AIDS along with other infectious, autoimmune, and immunological deficiency diseases. Viral Genetics recently announced their plan to market the cancer drug platform of Dr. Karen Newell, a University of Colorado researcher.
Viral Genetics announced previously the formation of a subsidiary, MetaCytoLynics to commercialize cancer therapies based on Dr. Newell’s breakthroughs in metabolic disruption technology. MetaCytonLynics will focus on the metabolic disruption technology while it continues to develop therapies to treat infectious disease and immune disorders using a thymus nuclear protein compound, for which Viral Genetics also has licensed intellectual property.
Metabolic disruption technology (MDT) involves the blocking of a tumor cell’s ability to generate energy from glucose or fatty acids in the body, with the purpose of killing the cancerous cells. Dr. Newell has shown that this process directly causes cancer cells to die and has completed successful animal studies. Viral Genetics thinks the outlook for the treatment is hopeful, as it is said to work in conjunction with commonly used drugs for chemotherapy.
Viral Genetics has the option to acquire exclusive rights for the MDT process from the University of Colorado and is currently in the stages of converting this option into a worldwide licensing agreement.
For less than the cost of a single trade commission, The Dean of CollegeStock.com offers his Honors Class Students his Ivy League Stock Picks and Honors Only real-time chat. To find out more about becoming The Dean’s newest Honors Class™ Student, and receive access to his Ivy League Stock Picks before the rest of the CollegeStock Community, visit
CollegeStock.com.
Visit CollegeStock.com now to sign up for The Dean’s FREE newsletter. You can also follow The Dean on Twitter: Twitter.com/_TheDean. The Dean of CollegeStock.com is so accessible that you can even connect with him by texting ‘thedean’ to 69302 on your wireless phone.
ABOUT VIRAL GENETICS:
Headquartered in San Marino, California, Viral Genetics discovers and develops drug therapies to treat infectious, autoimmune, and immunological deficiency disorders using its thymus nuclear protein compound (TNP). The company recently entered into an Exclusive License Agreement with the University of Colorado and V-Clip Pharmaceuticals (a subsidiary of the Company) to license technology developed by M. Karen Newell, Ph. D., which appears to explain TNP and provide a means to optimize therapies based on TNP for future clinical trials. Viral Genetics believes that its investigational HIV/AIDS drug based on TNP, called VGV-1, represents a unique approach to treating HIV due to the apparently novel mechanism, low toxicity profile, simple dosing regimen, and short-course of treatment. Visit www.viralgenetics.com for more information.
ABOUT THE COLLEGESTOCK GROUP
The CollegeStock Group, Inc. is the owner of CollegeStock.com. CollegeStock.com is the Internet’s #1 destination for stock market education. With a network of over 100,000 followers, CollegeStock.com focuses on speculative investing into penny stocks. Staying true to their motto of “Higher Learning for a Higher Net Worth,” CollegeStock.com is committed to focusing on real world methods on making money in the stock market and continues to be a reliable source for the best stock picks on the Internet. The Dean features daily commentary on his Ivy League stocks and also features Micro Cap Movies, Class Trip Documentaries, research reports and more. To feature a company on CollegeStock.com, please contact The Dean at Dean@CollegeStock.com.
NOT A BROKER/DEALER OR FINANCIAL ADVISOR
CollegeStock Group, Inc. is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company’s website, or in its publications, are made as of the date stated and are subject to change without notice.
DETAILS OF COMPENSATION RECEIVED
CollegeStock Group, Inc. has purchased five hundred and eighty seven thousand shares of Viral Genetics, Inc. (VRAL) in the open market and reserves the right to sell at anytime without notice.